A Phase I/II Study to Evaluate the Safety and Efficacy of the Allogeneic Injection of Expanded Adipose-derived Stem Cells to Patients With Knee Osteoarthritis
Phase of Trial: Phase I/II
Latest Information Update: 14 Nov 2017
At a glance
- Drugs Adipose-derived stem cells-UnicoCell (Primary) ; Hyaluronic acid
- Indications Osteoarthritis
- Focus Adverse reactions; Therapeutic Use
- Sponsors UnicoCell Biomed
- 08 Nov 2017 Number of arms has changed from 2 to 4 hence number of Planned number of patients changed from 24 to 56.
- 08 Nov 2017 Planned number of patients changed from 24 to 56.
- 08 Nov 2017 Planned End Date changed from 1 Sep 2017 to 1 Oct 2019.